Clinical Trial Update: Effect of Low-dose Radiotherapy on Tumor Immune Microenvironment in Oligometastases of NSCLC After Immunotherapy [Phase 2]

View source ↗

Summary

The Phase 2 trial investigating low-dose radiotherapy's effect on the tumor immune microenvironment in oligometastatic non-small cell lung cancer after immunoth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Hetian District People's Hospital | Conditions: Low-dose Radiotherapy, Tumor Microenvironment | Phase 2 | Status: WITHDRAWN